Audience
ProfessionalsStudents
Country / system
UK
Evidence relationship
Evidence-based NICE guideline covering medicines optimisation across populations; frailty-specific decisions may require additional evidence and individualised clinical judgement.
Guidance ID
8
Guidance type
Clinical guideline
Last checked
September 5, 2026
Official link
Practice note
Useful backbone for medication review and transitions of care; should be interpreted alongside multimorbidity guidance and condition-specific recommendations in people living with frailty.
Public
Public-friendly note
Supports regular review of medicines so that treatment remains useful, safe and aligned with the person's needs and priorities.
Publication / update date
March 4, 2015
Review due
Source
NICE
Status
Current
Topic
Medicines & deprescribingMultimorbidityFrailty
Website ready
Why it matters
Provides the NICE framework for safe and effective medicines use, including medicines reconciliation, structured medication review, polypharmacy and shared decision-making relevant to older adults.